Fibrosis in Hodgkin and non-Hodgkin lymphomas

Pathology Research and Practice

Volumn 203, Issue 10, 2007, Pages 725-730

  Tataroglu, Canten ^a   Sarioglu, Sülen ^b   Kargi, Aydanur ^b   Özkal, Sermin ^b   Aydin, Özlem ^c  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

^c MERSIN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Fibrosis; Lymphoma; Mast cells; Quantitative histochemistry

Indexed keywords

STREPTAVIDIN;

ARTICLE; CELL COUNT; COMPUTER PROGRAM; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DIGITAL IMAGING; FIBROSIS; HISTOCHEMISTRY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; MAST CELL; MIXED CELLULARITY HODGKIN LYMPHOMA; NODULAR SCLEROSIS HODGKIN LYMPHOMA; NONHODGKIN LYMPHOMA; QUANTITATIVE ANALYSIS; RANK SUM TEST; TISSUE SECTION;

EID: 34548614127     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2007.07.006     Document Type: Article

References (32)

1. Aldinucci D., Lorenzon D., Olivo K., Rapana B., and Gattei V. Interaction between tissue fibroblasts in lymph nodes and Hodgkin/Reed-Sternberg cells. Leuk. Lymphoma 45 9 (2004) 1731-1739
2. Armbrust T., Batusic D., and Ringe B. Mast cell distribution in human liver disease and experimental rat liver fibrosis: indications form mast cell participation in development of liver fibrosis. J. Hepatol. 26 (1997) 1042-1054
3. Brouty-Boye D., Potin-Clemenceau C., Doucet C., Jasmin C., and Azzarone B. Chemokines and CD40 expression in human fibroblasts. Eur. J. Immunol. 30 (2000) 914-919
4. Clodi K., Asgari Z., Younes M., Palmer J.L., Cabanillas F., Carbone A., Andreef M., and Younes A. Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin disease. Cancer 94 (2002) 1-5
5. Crivellato E., Nico B., Vacca A., Dammaco F., and Rebatti D. Mast cell heterogeneity in B-cell non-Hodgkin's lymphomas: an ultrastructural study. Leuk. Lymphoma 43 11 (2002) 2201-2205
6. Fischer M., Juremalm M., Olsson N., Backlin C., Sundström C., Nilsson K., Enblad G., and Nilsson G. Expression of CCL5/RANTES by Hodgkin and Reed-Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue. Int. J. Cancer 107 (2003) 197-201
7. Flanders K.C. Smad3 as a mediator of the fibrotic response. Int. J. Exp. Pathol. 85 (2004) 47-64
8. Fukushima H., Ohsawa M., Ikura Y., Naruko T., Sugama Y., Suekane T., Kitabayashi C., Inoue T., Hino M., and Ueda M. Mast cells in diffuse large B-cell lymphoma; their role in fibrosis. Histopathology 49 (2006) 498-505
9. Gali S.J. Mast cells and basophils. Curr. Opin. Hematol. 7 (2000) 32-39
10. Gruber B., Marchese M.J., and Kew R. Angiogenic factors stimulate mast cell migration. Blood 86 (1995) 2488-2493
11. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues (2001), IARC Press, Lyon
12. Jundt F., Anagnostopoulos I., Bommert K., Emmerich F., Müller G., Foss H.D., Royer H.D., Stein H., and Dörken B. Hodgkin/Reed-Sternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils. Blood 94 (1999) 2065-2071
13. Kavukcu S., Soylu A., Turkmen M., Kuralay F., Yi{dotless}lmaz O., and Sarioglu S. Ureteroperitoneostomy in the management of hypoproteinemia in nephrotic rats with normal renal function. Tohoku J. Exp. Med. 201 (2003) 67-73
14. Mach F., Schonbeck U., Sukhova G.K., Atkinson E., and Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 394 (1998) 200-203
15. Miyazawa S., Hotta O., Doi N., Natori Y., Nishikawa K., and Natori Y. Role of mast cells in the development of renal fibrosis: use of mast cell deficient rats. Kidney Int. 65 (2004) 2228-2237
16. Molin D., Edstöm A., Glimelius I., Gimelius B., and Nilsson G. Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma. Br. J. Haematol. 119 (2002) 122-124
17. Molin D., Fisher M., Xiang Z., Larsson U., Harvima I., Venge P., Nilsson K., Sunström C., Enblad G., and Nilsson G. Mast cell express functional CD30 ligand and are the predominant CD30L-positive cells in hodgkin disease. Br. J. Haematol. 114 (2001) 616-623
18. Moyer K.E., Saggers G.C., and Erlich P.E. Mast cells promote fibroblast populated collagen lattice contraction through gap junction intercellular communication. Wound Rep Reg 12 (2004) 269-275
19. Nilsson G., and Nilsson K. Effects of IL-13 on immediate-early response gene expression, phenotype and differentiation of human mast cells. Comparison with IL-4. Eur. J. Immunol. 25 (1995) 870-873
20. Ohsima K., Akaiwa M., Umeshita R., Suzimaya J., Izuhara K., and Kikuchi M. Interleukin-13 and interleukin-13 receptor in Hodgkin's disease: possible autocrine mechanism and involvement in fibrosis. Histopatholgy 38 (2001) 368-375
21. Ohsima K., Sugihara M., Suzumiya J., Haraoka S., Kanda M., Shimazaki K., Katoh K., Kumagawa M., and Kikuchi M. Basic fibroblast growth factor and fibrosis in Hodgkin's disease. Pathol. Res. Pract. 195 (1999) 149-155
22. Otsubo S., Nitta K., Uchida K., Yumura W., and Nihei H. Mast cells and tubulointerstitial fibrosis in patients with anca associated glomerulonephritis. Clin. Exp. Nephrol. 7 (2003) 41-47
23. Pinheiro S.W., Rua A.M.O., Etchebehere R.M., Cancado C.G., Chica J.E.L., Lopes E.R., and Adad S.J. Morphometric study of the fibrosis and mast cell count in the circular colon musculature of chronic chagas patients with and without megacolon. Rev. Soc. Brasil Med. Trop. 36 4 (2003) 461-466
24. Poppema S., Potters M., Emmens R., Visser L., and Berg A. Immune reactions in classical Hodgkin's lymphoma. Semin. Hematol. 36 (1999) 253-259
25. Roche W.R. Mast cells and tumors. Am. J. Pathol. 119 (1985) 57-64
26. Samoszuk M., Kanakubo E., and Chan J.K. Degranulating mast cells in fibrotic regions of human tumors and evidence that mast cell heparin interferes with growth of tumor cells through a mechanism involving fibroblasts. BMC Cancer 5 (2005) 121-131
27. Sarioglu S., Celik A., Sakar M., Sonmez D., and Tekis D. Methenamine silver staining quantitative digital histochemistry in chronic allograft nephropathy. Transplant Proc. 36 10 (2004) 2991-2992
28. Sime P., and O'Reilly K.M. Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment. Clin. Immunol. 99 (2001) 308-319
29. Sis B., Sarioglu S., Somken S., Sakar M., Kupelioglu A., and Fuzun M. Desmoplasia measured by computer assisted image analysis: an independent prognostic marker in colorectal carcinoma. J. Clin. Pathol. 58 (2005) 32-38
30. Skinnider B.F., Elia A.J., Gascoyne R.D., Trümper L.H., Bonin F., Kapp U., Patterson B., Snow B.E., and Mak T.W. Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 97 (2001) 250-255
31. Sugiura T., Kawaguchi Y., Harigai M., Tagaki K., Ohta S., Fukasawa C., Hara M., and Kamatani N. Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractand protein-1 production. J. Immunol. 164 (2000) 6593-6600
32. Yamamoto T., Katayama I., and Nishioka K. Role of mast cells in dermatofibroma: recent viewpoints into the pathogenesis. Eur. J. Dermatol. 13 5 (2003) 419-423